跳至主要内容
临床试验/NCT01425411
NCT01425411已完成4 期

Effect of Valsartan on Left Ventricular Myocardial Functions in Hypertensive Patients With Left Ventricular Hypertrophy

Mustafa Kemal University1 个研究点 分布在 1 个国家目标入组 38 人开始时间: 2006年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
38
试验地点
1
主要终点
change from baseline in midwall fractional shortening (mFS) and tissue Doppler systolic wave (Sm) measured by echocardiography at six months

研究概览

简要总结

The study hypothesis: Valsartan as an angiotensin II receptor blocker treatment has beneficial effects on both midwall mechanics and myocardial functions in hypertensive patients with Left ventricular hypertrophy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • hypertension with left ventricular hypertrophy

排除标准

  • clinical or laboratory evidence of secondary hypertension
  • heart failure
  • ischemic heart disease
  • valvular heart disease
  • arrhythmias
  • peripheral vascular disease
  • chronic obstructive pulmonary disease
  • neurologic disorders
  • diabetes mellitus
  • renal dysfunction
  • notable systemic disease

研究组 & 干预措施

Valsartan treatment

Experimental

干预措施: valsartan (Drug)

结局指标

主要结局

change from baseline in midwall fractional shortening (mFS) and tissue Doppler systolic wave (Sm) measured by echocardiography at six months

时间窗: six months

次要结局

  • change from baseline in systolic and diastolic blood pressure at six months(six months)
  • change from baseline in left ventricular mass index measured by echocardiography at six months(six months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Nagehan Kucukler

MD

Mustafa Kemal University

研究点 (1)

Loading locations...

相似试验